| BioCyc:META_PWY-7588 |
ursodeoxycholate biosynthesis (bacteria) |
| Reactome:R-RNO-9748784 |
Drug ADME |
| Reactome:R-MMU-9757110 |
Prednisone ADME |
| Reactome:R-HSA-9757110 |
Prednisone ADME |
| Reactome:R-MMU-9748784 |
Drug ADME |
| Reactome:R-HSA-9748784 |
Drug ADME |
| Reactome:R-RNO-9757110 |
Prednisone ADME |
| WikiPathways:WP5280 |
Glucocorticoid biosynthesis |
| WikiPathways:WP4545 |
Oxysterols derived from cholesterol |
| PathBank:SMP0030406 |
Androstenedione Metabolism |
| PathBank:SMP0120633 |
Succinyl CoA: 3-Ketoacid CoA Transferase Deficiency |
| PathBank:SMP0000373 |
Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency |
| PathBank:SMP0000576 |
21-Hydroxylase Deficiency (CYP21) |
| PathBank:SMP0000718 |
3-beta-Hydroxysteroid Dehydrogenase Deficiency |
| PathBank:SMP0000575 |
11-beta-Hydroxylase Deficiency (CYP11B1) |
| PathBank:SMP0000717 |
Apparent Mineralocorticoid Excess Syndrome |
| PathBank:SMP0000130 |
Steroidogenesis |
| PathBank:SMP0000371 |
Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH |
| PathBank:SMP0000577 |
Corticosterone Methyl Oxidase I Deficiency (CMO I) |
| PathBank:SMP0000372 |
Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia Due to 17 alpha-Hydroxylase Deficiency |
| PathBank:SMP0000566 |
17-alpha-Hydroxylase Deficiency (CYP17) |
| PathBank:SMP0000578 |
Corticosterone Methyl Oxidase II Deficiency (CMO II) |
| PathBank:SMP0063631 |
Ketone Body Metabolism |